SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-18-000011
Filing Date
2018-01-05
Accepted
2018-01-05 15:11:25
Documents
1
Group Members
ARCH VENTURE PARTNERS VII, L.P.ARCH VENTURE PARTNERS VII, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A - AMENDMENT NO. 2 pulmatrix13da_18144.htm SC 13D/A 190233
  Complete submission text file 0001072613-18-000011.txt   191983
Mailing Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631
Business Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631 773-380-6600
Arch Venture Fund VII LP (Filed by) CIK: 0001402439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Subject) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88056 | Film No.: 18513155
SIC: 2834 Pharmaceutical Preparations